Skip to search formSkip to main contentSkip to account menu

TC 2559

Known as: (E)-N-methyl-4-(3-(5-ethoxypyridin)yl)-3-buten-1-amine, TC-2559, TC2559 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A lithium enolate derived from an acetonide-protected pyroglutaminol undergoes a highly selective azaaldol addition with (E)-N… 
2015
2015
Neuropathic pain is often refractory to conventional analgesics including opioids and non‐steroidal anti‐inflammatory drugs… 
2014
2014
Background: The α4/β2 and α4/α4 interfaces of the (α4β2)2α4 nicotinic acetylcholine receptor house structurally different agonist… 
2013
2013
An iodine and caesium carbonate amine oxidation protocol is described. Non-branched secondary benzylamines were cleanly oxidised… 
2011
2011
BackgroundTC-2559 is a selective α4β2 subtype of nicotinic acetylcholine receptor (nAChR) partial agonist and α4β2 nAChR… 
2006
2006
The in vivo effects of a selective partial agonist for neuronal nicotinic acetylcholine receptor (nAChRs) α4β2 subtype, TC‐2559… 
2006
2006
The neuronal nicotinic acetylcholine receptor alpha4 and beta2 subunits expressed in heterologous expression systems assemble… 
2006
2006
Nicotinic acetylcholine receptors (nAChR) are widely expressed throughout the nervous system, are involved in some fast… 
2003
2003
The ability of alpha4beta2 nicotinic acetylcholine receptors to modulate dopaminergic (DA) cell activity in the ventral tegmental…